Search Results - "Mease, P.J"

Effect Of Certolizumab Pegol On Workplace And Household Productivity In United States Patients With Rheumatoid Arthritis With Or Without Prior Anti-Tnf Exposure: Results From The Predict Study by Kavanaugh, A, Mease, P.J, Strand, V, Purcaru, O, Curtis, J.R

Get full text

Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol: 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study by Gladman, D, Fleischmann, R, Szegvari, B, Peterson, L, Mease, P.J

Get full text

Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Psoriatic Arthritis by Kavanaugh, A, Gladman, D, van, der Heijde D, Purcaru, O, Mease, P.J

Get full text

High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity: Baseline Results from the Rapid-PSA Study by Kavanaugh, A, Mease, P.J, Purcaru, O, van der Heijde, D

Get full text

Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol: 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study by Gladman, D, Fleischmann, R, Coteur, G, Peterson, L, Mease, P.J

Get full text

Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis: 48-Week Results from the Rapid-PsA Study by Kavanaugh, A, Gladman, D, van der Heijde, D, Purcaru, O, Mease, P.J

Get full text

Comparing Health-Related Quality of Life Across Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis: Analyses from Certolizumab Pegol Clinical Trial Baseline Data by Mease, P.J, van Tubergen, A, Deodhar, A, Coteur, G, Nurminen, T, van der Heijde, D

Get full text

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data by Deodhar, A, Mease, P J, McInnes, I B, Baraliakos, X, Reich, K, Blauvelt, A, Leonardi, C, Porter, B, Das Gupta, A, Widmer, A, Pricop, L, Fox, T

“…Secukinumab, a fully human immunoglobulin G1-kappa monoclonal antibody that directly inhibits interleukin (IL)-17A, has been shown to have robust efficacy in…”
Get full text

CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis by Mease, P.J., Warren, R.B., Nash, P., Grouin, J.M., Willems, D., Taieb, V., Eells, J., McInnes, I.

Get full text

PCR229 Achieving Increasingly Stringent Disease Control Criteria Was Associated with Greater Quality of Life Improvements in Patients with Active Psoriatic Arthritis: Results from BE OPTIMAL and BE COMPLETE/BE VITAL up to 1 Year by Kristensen, L.E., Coates, L.C., Mease, P.J., Merola, J.F., Gisondi, P., Nash, P., Ogdie, A.R., Tillett, W., Ink, B., Bajracharya, R., Taieb, V., Lambert, J., Willems, D., Walsh, J.A.

Get full text

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up by Lebwohl, M., Deodhar, A., Griffiths, C.E.M., Menter, M.A., Poddubnyy, D., Bao, W., Jehl, V., Marfo, K., Primatesta, P., Shete, A., Trivedi, V., Mease, P.J.

“…Summary Background Data on the use of biologic therapy and malignancy risk are inconsistent due to limited long‐term robust studies. Objectives To assess the…”
Get full text

PCR68 Association of Clinical Response Criteria and Disease Activity Levels with Physical Function and HRQoL in Patients with Axial Spondyloarthritis: 52-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies by Magrey, M., Deodhar, A., Mease, P.J., Navarro-Compán, V., Ramiro, S., Fleurinck, C., Taieb, V., Mørup, M., Massow, U., Kay, J.

Get full text

SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis by Mease, P.J, Gladman, D.D., Merola, J.F, Nash, P., Grieve, S., Laliman-Khara, V., Willems, D., Taieb, V., Prickett, A.R, Coates, L.C

Get full text

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry by Mease, P.J., Palmer, J.B., Hur, P., Strober, B.E., Lebwohl, M., Karki, C., Reed, G.W., Etzel, C.J., Greenberg, J.D., Helliwell, P. S.

“…Background Despite increasing awareness of the disease, rates of undiagnosed psoriatic arthritis (PsA) are high in patients with psoriasis (PsO). The validated…”
Get full text

PMS76 - Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol: 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study by Gladman, D., Fleischmann, R., Szegvari, B., Peterson, L., Mease, P.J.

Get full text

PMS66 - Effect Of Certolizumab Pegol On Workplace And Household Productivity In United States Patients With Rheumatoid Arthritis With Or Without Prior Anti-Tnf Exposure: Results From The Predict Study by Kavanaugh, A., Mease, P.J., Strand, V., Purcaru, O., Curtis, J.R.

Get full text

PMS65 - High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity: Baseline Results from the Rapid-PSA Study by Kavanaugh, A., Mease, P.J., Purcaru, O., van der Heijde, D.

Get full text

PMS81 - Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol: 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study by Gladman, D., Fleischmann, R., Coteur, G., Peterson, L., Mease, P.J.

Get full text

PMS84 - Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Psoriatic Arthritis by Kavanaugh, A., Gladman, D., van, der Heijde D., Purcaru, O., Mease, P.J.

Get full text

L’aprémilast améliore l’état des patients atteints du rhumatisme psoriasique de forme oligoarticulaire : analyse principale de l’essai thérapeutique contrôlé vs placebo FOREMOST by Gossec, L., Gladman, D., Coates, L.C., Aelion, J., Vasandani, J., Reddy, J., Wang, R., Brunori, M., Colgan, S., Mease, P.J.

Get full text